Literature DB >> 19279003

Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7.

Masakiyo Sakaguchi1, Ken Kataoka, Fernando Abarzua, Ryuta Tanimoto, Masami Watanabe, Hitoshi Murata, Swe Swe Than, Kaoru Kurose, Yuji Kashiwakura, Kazuhiko Ochiai, Yasutomo Nasu, Hiromi Kumon, Nam-ho Huh.   

Abstract

We previously showed that the tumor suppressor gene REIC/Dkk-3, when overexpressed by an adenovirus (Ad-REIC), exhibited a dramatic therapeutic effect on human cancers through a mechanism triggered by endoplasmic reticulum stress. Adenovirus vectors show no target cell specificity and thus may elicit unfavorable side effects through infection of normal cells even upon intra-tumoral injection. In this study, we examined possible effects of Ad-REIC on normal cells. We found that infection of normal human fibroblasts (NHF) did not cause apoptosis but induced production of interleukin (IL)-7. The induction was triggered by endoplasmic reticulum stress and mediated through IRE1alpha, ASK1, p38, and IRF-1. When Ad-REIC-infected NHF were transplanted in a mixture with untreated human prostate cancer cells, the growth of the cancer cells was significantly suppressed. Injection of an IL-7 antibody partially abrogated the suppressive effect of Ad-REIC-infected NHF. These results indicate that Ad-REIC has another arm against human cancer, an indirect host-mediated effect because of overproduction of IL-7 by mis-targeted NHF, in addition to its direct effect on cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279003      PMCID: PMC2682872          DOI: 10.1074/jbc.M808002200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Interleukin-7: from bench to clinic.

Authors:  Terry J Fry; Crystal L Mackall
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

2.  A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines.

Authors:  T Tsuji; M Miyazaki; M Sakaguchi; Y Inoue; M Namba
Journal:  Biochem Biophys Res Commun       Date:  2000-02-05       Impact factor: 3.575

3.  Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication.

Authors:  P W Miller; S Sharma; M Stolina; L H Butterfield; J Luo; Y Lin; M Dohadwala; R K Batra; L Wu; J S Economou; S M Dubinett
Journal:  Hum Gene Ther       Date:  2000-01-01       Impact factor: 5.695

4.  Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer.

Authors:  I Nozaki; T Tsuji; O Iijima; Y Ohmura; A Andou; M Miyazaki; N Shimizu; M Namba
Journal:  Int J Oncol       Date:  2001-07       Impact factor: 5.650

5.  Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells.

Authors:  Kazuyasu Kobayashi; Mamoru Ouchida; Toshiya Tsuji; Hiroko Hanafusa; Masahiro Miyazaki; Masayoshi Namba; Nobuyoshi Shimizu; Kenji Shimizu
Journal:  Gene       Date:  2002-01-09       Impact factor: 3.688

6.  Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial.

Authors:  B Wittig; A Märten; T Dorbic; S Weineck; H Min; S Niemitz; B Trojaneck; D Flieger; S Kruopis; A Albers; J Löffel; A Neubauer; P Albers; S Müller; T Sauerbruch; T Bieber; D Huhn; I G Schmidt-Wolf
Journal:  Hum Gene Ther       Date:  2001-02-10       Impact factor: 5.695

Review 7.  Tumor reversion: correction of malignant behavior by microenvironmental cues.

Authors:  Paraic A Kenny; Mina J Bissell
Journal:  Int J Cancer       Date:  2003-12-10       Impact factor: 7.396

8.  Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-beta induction via X-box binding protein 1.

Authors:  Judith A Smith; Matthew J Turner; Monica L DeLay; Erin I Klenk; Dawn P Sowders; Robert A Colbert
Journal:  Eur J Immunol       Date:  2008-05       Impact factor: 5.532

9.  Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis.

Authors:  Yuji Kashiwakura; Kazuhiko Ochiai; Masami Watanabe; Fernando Abarzua; Masakiyo Sakaguchi; Munenori Takaoka; Ryuta Tanimoto; Yasutomo Nasu; Nam-Ho Huh; Hiromi Kumon
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

Review 10.  Cytotoxic cells in immunodeficient athymic mice.

Authors:  W Budzynski; C Radzikowski
Journal:  Immunopharmacol Immunotoxicol       Date:  1994-08       Impact factor: 2.730

View more
  25 in total

1.  Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.

Authors:  Thanh H Dellinger; Kestutis Planutis; Danielle D Jandial; Ramez N Eskander; Micaela E Martinez; Xiaolin Zi; Bradley J Monk; Randall F Holcombe
Journal:  Gynecol Oncol       Date:  2012-04-30       Impact factor: 5.482

2.  Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma.

Authors:  Liran Zhou; Hongmei Husted; Todd Moore; Mason Lu; Defeng Deng; Yan Liu; Vijaya Ramachandran; Thiruvengadam Arumugam; Christof Niehrs; Huamin Wang; Paul Chiao; Jianhua Ling; Michael A Curran; Anirban Maitra; Mien-Chie Hung; Jeffrey E Lee; Craig D Logsdon; Rosa F Hwang
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

3.  Dickkopf-3 attenuates pressure overload-induced cardiac remodelling.

Authors:  Yan Zhang; Yu Liu; Xue-Hai Zhu; Xiao-Dong Zhang; Ding-Sheng Jiang; Zhou-Yan Bian; Xiao-Fei Zhang; Ke Chen; Xiang Wei; Lu Gao; Li-Hua Zhu; Qinglin Yang; Guo-Chang Fan; Wayne B Lau; Xinliang Ma; Hongliang Li
Journal:  Cardiovasc Res       Date:  2014-01-09       Impact factor: 10.787

4.  Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Authors:  Ramez N Eskander; Shamshad Ali; Thanh Dellinger; Heather A Lankes; Leslie M Randall; Nilsa C Ramirez; Bradley J Monk; Joan L Walker; Eric Eisenhauer; Bang H Hoang
Journal:  Int J Gynecol Cancer       Date:  2016-01       Impact factor: 3.437

5.  Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3'-side of the transgene.

Authors:  Endy Widya Putranto; Rie Kinoshita; Masami Watanabe; Takuya Sadahira; Hitoshi Murata; Ken-Ichi Yamamoto; Junichiro Futami; Ken Kataoka; Yusuke Inoue; I Made Winarsa Ruma; I Wayan Sumardika; Chen Youyi; Miyoko Kubo; Yoshihiko Sakaguchi; Kenji Saito; Yasutomo Nasu; Hiromi Kumon; Nam-Ho Huh; Masakiyo Sakaguchi
Journal:  Oncol Lett       Date:  2017-05-17       Impact factor: 2.967

6.  Adenovirus-mediated expression of truncated E2F-1 suppresses tumor growth in vitro and in vivo.

Authors:  Jorge G Gomez-Gutierrez; Aracely Garcia-Garcia; Hongying Hao; Xiao-Mei Rao; Roberto Montes de Oca-Luna; Heshan S Zhou; Kelly M McMasters
Journal:  Cancer       Date:  2010-09-15       Impact factor: 6.860

7.  Overexpression of Dickkopf-3 induces apoptosis through mitochondrial pathway in human colon cancer.

Authors:  Zi-Rong Yang; Wei-Guo Dong; Xiao-Fei Lei; Meng Liu; Qi-Sheng Liu
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

8.  Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer.

Authors:  H Sawahara; H Shiraha; D Uchida; H Kato; T Nagahara; M Iwamuro; J Kataoka; S Horiguchi; M Watanabe; M Sakaguchi; A Takaki; K Nouso; Y Nasu; H Kumon; H Okada
Journal:  Cancer Gene Ther       Date:  2016-07-29       Impact factor: 5.987

9.  Identification of a progenitor cell population destined to form fracture fibrocartilage callus in Dickkopf-related protein 3-green fluorescent protein reporter mice.

Authors:  Yu Mori; Douglas Adams; Yusuke Hagiwara; Ryu Yoshida; Masayuki Kamimura; Eiji Itoi; David W Rowe
Journal:  J Bone Miner Metab       Date:  2015-09-14       Impact factor: 2.626

10.  The induction of antigen-specific CTL by in situ Ad-REIC gene therapy.

Authors:  Y Ariyoshi; M Watanabe; S Eikawa; C Yamazaki; T Sadahira; T Hirata; M Araki; S Ebara; Y Nasu; H Udono; H Kumon
Journal:  Gene Ther       Date:  2016-02-02       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.